BioWorld

Nov. 2, 2004

View Archived Issues

Nastech Gets Approvable Letter For Nascobal Spray

Nastech Pharmaceutical Co. Inc.'s reformulated treatment for vitamin B-12 deficiency, Nascobal (cyanocobalamin) Nasal Spray, received an approvable letter from the FDA. (BioWorld Today) Read More

MedImmune Starts Enrolling Pivotal Phase III Numax Trial

Read More

Looking Upstream For New Cancer Metastasis Insights

Read More

Hemispherx Gears Up For NDA With Ampligen Data

Read More

Correction

Read More

News From AASLD

Read More

Other News To Note

Read More